US2011065603A1PendingUtilityA1
Method for a Highly Sensitive Detection and Quantification of Biomolecules Using Secondary Ion Mass Spectrometry (SIMS) and Related Technologies
Est. expiryMar 12, 2028(~1.7 yrs left)· nominal 20-yr term from priority
Y02A50/30G01N 33/543G01N 23/2258G01N 33/6848G01N 2458/15
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for detecting and quantifying the presence or absence of a number of biomolecules in a sample using the SIMS technique and arrays for use in said method.
Claims
exact text as granted — not AI-modified1 . An array comprising a substantially planar substrate having a conducting surface and a number of discrete areas containing probes being labeled with at least one rare, stable or unstable isotope or exogenous isotope, wherein said probes are able to bind or to interact with target biomolecules.
2 . An array according to claim 1 , wherein said substantially planar substrate having a conducting surface is a silicon wafer.
3 . An array according to claim 1 , wherein said probes are labeled with at least one heavy stable isotope selected in the group 2 H, 13 C, 15 N, 17 O, 18 O, 33 S, 34 S and 36 S, or with at least one unstable isotope selected in the group 3 H and 14 C or with at least one exogenous isotope selected in the group of 79 Br and 81 Br.
4 . An array according to claim 1 , wherein said array is a microarray wherein each discrete area has one of the dimensions length, width or diameter being from 1 μm to 1000 μm.
5 . An array according to claim 4 , wherein each discrete area is a microwell that comprises probes being labeled with at least one rare, stable or unstable isotope or exogenous isotope.
6 . An array according to claim 1 , wherein said array is a nanoarray wherein each discrete area has one of the dimensions length, width or diameter being from 1 nm to 1000 nm.
7 . An array according to claim 6 , wherein each discrete area is a nanowell that comprises probes being labeled with at least one rare, stable or unstable isotope or exogenous isotope.
8 . An array according to claim 5 , wherein each microwell comprises a number of nanowells, and said nanowells comprise the probes being labeled with at least one rare, stable or unstable isotope or exogenous isotope.
9 . A method for detecting and quantifying in at least one sample the presence or absence of at least one biomolecule, comprising:
(a) contacting said at least one sample with an array according to claim 1 , (b) washing and drying the array, (c) detecting and counting by SIMS the common secondary ions along with the corresponding rare secondary ions.
10 . The method according to claim 9 , wherein each sample to be tested is contacted with one or more discrete area of the array.
11 . The method according to claim 9 , wherein said sample to be tested is a single cell.
12 . The method according to claim 9 for determining a molecular atlas of the sample tested, wherein said molecular atlas is the determination of the transcriptome, proteome, lipidome, metabolome, glycome and/or interactome of said sample.
13 . The method according to claim 9 for predicting a predisposition to a disease, or for diagnosing a disease in a subject in need thereof.
14 . The method according to claim 9 for monitoring the efficacy of a therapeutic agent administrated to a subject to treat a disease.
15 . The method according to claim 9 for screening therapeutic agents.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.